Nektar Therapeutics Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 71.93M159.04M71.48M81.19M148.92M200.71M230.78M165.44M307.71M1193.32M114.62M152.91M101.91M92.06M90.12M98.43M
Cost of Revenue 30.95M25.67M21.89M30.43M38.51M28.53M34.10M30.21M30.55M24.41M21.37M19.48M24.90M21.64M37.05M42.05M
Gross Profit 40.98M133.37M49.59M50.76M110.41M172.17M196.68M135.22M277.16M1168.91M93.24M133.44M77.01M70.42M53.07M56.38M
Operating items
Research & Development 95.11M108.06M126.77M148.68M190.01M147.73M182.79M203.80M268.46M399.54M434.57M408.68M400.27M218.32M114.16M120.91M
Selling, General & Administrative 41.01M40.99M46.76M41.61M40.53M40.92M43.27M44.27M52.36M81.44M98.71M104.68M122.84M92.33M77.42M76.75M
Restructuring Costs 31.69M5.49M
Other Operating Expenses 30.95M38.24M21.89M32.10M38.51M28.53M34.10M30.21M46.53M24.41M21.37M64.67M24.90M125.87M156.74M5.97M
Operating Expenses 167.06M187.29M195.42M222.39M269.05M217.19M260.15M278.29M367.35M505.39M554.65M578.03M548.01M468.22M353.81M203.62M
Operating Income -95.13M-28.25M-123.94M-141.20M-120.13M-19.05M-29.37M-112.86M-59.64M687.93M-440.04M-425.11M-446.10M-376.17M-263.68M-105.20M
EBIT -95.13M-28.25M-123.94M-141.20M-120.13M-19.05M-29.37M-112.86M-59.64M687.93M-440.04M-425.11M-446.10M-376.17M-263.68M-105.20M
Non-operating items
Interest & Investment Income 3.69M1.54M2.24M2.31M0.73M2.73M6.78M19.01M14.50M
Other Non Operating Income 0.85M0.83M-1.04M3.30M1.12M0.81M-14.08M2.39M4.52M37.57M46.34M18.28M-8.02M33.43M-6.25M-0.39M
Non Operating Income -7.64M-8.80M-9.02M-30.25M-39.64M-37.94M-51.30M-39.79M-36.43M37.57M46.34M-18.84M-77.18M11.18M-12.57M-14.00M
Net income details
EBT -103.30M-39.32M-135.88M-174.26M-161.07M-56.41M-81.93M-155.38M-96.08M682.73M-440.05M-443.95M-524.44M-371.90M-276.26M-119.23M
Tax Provisions -0.25M0.88M1.02M0.89M2.25M-0.51M0.53M0.99M0.62M1.41M0.61M0.49M0.66M3.21M-0.20M-0.24M
Profit After Tax -102.52M-37.94M-133.98M-171.85M-162.01M-53.92M-81.18M-153.52M-96.69M681.31M-440.67M-444.44M-523.84M-368.20M-276.06M-118.96M
Income from Continuing Operations -103.04M-40.20M-136.90M-175.15M-163.31M-55.90M-82.46M-156.37M-96.69M681.31M-440.67M-444.44M-525.10M-375.12M-276.06M-118.99M
Consolidated Net Income -103.04M-40.20M-136.90M-175.15M-163.31M-55.90M-82.46M-156.37M-96.69M681.31M-440.67M-444.44M-525.10M-375.12M-276.06M-118.99M
Income towards Parent Company -103.04M-40.20M-136.90M-175.15M-163.31M-55.90M-82.46M-156.37M-96.69M681.31M-440.67M-444.44M-525.10M-375.12M-276.06M-118.99M
Net Income towards Common Stockholders -103.04M-40.20M-136.90M-175.15M-163.31M-55.90M-82.46M-156.37M-96.69M681.31M-440.67M-444.44M-525.10M-375.12M-276.06M-118.99M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 6.21M6.29M7.63M7.68M7.74M8.56M8.90M10.19M10.50M11.54M11.73M11.96M12.30M12.53M12.72M12.30M
Shares Outstanding (Diluted Average) 139.60M155.95M180.12M174.99M178.58M183.30M187.14M190.00M205.66M
EBITDA -95.13M-28.25M-123.94M-141.20M-120.13M-19.05M-29.37M-112.86M-59.64M687.93M-440.04M-425.11M-446.10M-376.17M-263.68M-105.20M
Tax Rate 0.24%0.91%0.21%0.07%0.20%